What the Research Says
Zinc is a critical nutrient with diverse applications in health and disease management. In dermatology, Yee et al. (2020) conducted a systematic review and meta-analysis confirming that oral zinc supplementation significantly reduces inflammatory acne compared to placebo. Specifically, zinc gluconate at 30 mg elemental zinc/day for three months has been shown to reduce acne lesion counts by approximately one-third. Additionally, zinc is essential for all phases of wound healing— inflammation, proliferation, and remodeling—and deficiency can dramatically impair skin repair (Lansdown et al., 2007).
Beyond dermatology, recent studies highlight zinc's broader therapeutic potential. Hsu et al. (2024) found that zinc supplementation significantly reduced pain severity in primary dysmenorrhea compared to placebo, based on a meta-analysis of six RCTs involving 739 women. Similarly, Ali et al. (2024) reviewed 38 RCTs and concluded that zinc supplementation reduces acute diarrhea duration by approximately 13 hours and increases recovery rates in children under 10.
Zinc deficiency is also prevalent in certain conditions. Zupo et al. (2022) reported higher zinc deficiency prevalence in Crohn's disease (54%) compared to ulcerative colitis (41%) among individuals with inflammatory bowel disease. Furthermore, Banik and Ghosh (2022) highlighted the association between low zinc status and coronary artery disease through a systematic review and meta-analysis of 10 studies.
Overall, zinc supplementation offers diverse benefits across multiple health conditions, supported by robust evidence from recent systematic reviews and meta-analyses.
